Waltham, MA, United States of America

Carl Uli Bialucha

This inventor holds 1 USPTO granted patent. Top assignee: Xilio Development, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Uli Bialucha. Retrieved from https://idiyas.com/inventor/carl-uli-bialucha-1mb196it

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Carl Uli Bialucha

Introduction

Carl Uli Bialucha is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of cytokines. His work has the potential to impact various therapeutic applications.

Latest Patents

Bialucha holds a patent titled "Masked IL-2 Cytokines and Methods of Use Thereof." This patent represents his innovative approach to enhancing the efficacy of cytokines in medical treatments. The patent showcases his expertise and commitment to advancing scientific knowledge.

Career Highlights

Bialucha is currently employed at Xilio Development, Inc., where he continues to work on groundbreaking research. His role at the company allows him to collaborate with other experts in the field and contribute to the development of novel therapies.

Collaborations

One of his notable coworkers is Ertan Eryilmaz. Together, they work on projects that aim to push the boundaries of current medical technologies.

Conclusion

Carl Uli Bialucha's contributions to the field of biotechnology through his patent and work at Xilio Development, Inc. highlight his role as an innovative inventor. His efforts in developing cytokine therapies are paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…